Cargando…
The value of demonstration projects for new interventions: The case of human papillomavirus vaccine introduction in low- and middle-income countries
Demonstration projects or pilots of new public health interventions aim to build learning and capacity to inform country-wide implementation. Authors examined the value of HPV vaccination demonstration projects and initial national programmes in low-income and lower-middle-income countries, includin...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5027708/ https://www.ncbi.nlm.nih.gov/pubmed/27159786 http://dx.doi.org/10.1080/21645515.2016.1178433 |
_version_ | 1782454283718885376 |
---|---|
author | Howard, N. Mounier-Jack, S. Gallagher, K. E. Kabakama, S. Griffiths, U. K. Feletto, M. LaMontagne, D. S. Burchett, H. E. D. Watson-Jones, D. |
author_facet | Howard, N. Mounier-Jack, S. Gallagher, K. E. Kabakama, S. Griffiths, U. K. Feletto, M. LaMontagne, D. S. Burchett, H. E. D. Watson-Jones, D. |
author_sort | Howard, N. |
collection | PubMed |
description | Demonstration projects or pilots of new public health interventions aim to build learning and capacity to inform country-wide implementation. Authors examined the value of HPV vaccination demonstration projects and initial national programmes in low-income and lower-middle-income countries, including potential drawbacks and how value for national scale-up might be increased. Data from a systematic review and key informant interviews, analyzed thematically, included 55 demonstration projects and 8 national programmes implemented between 2007-2015 (89 years' experience). Initial demonstration projects quickly provided consistent lessons. Value would increase if projects were designed to inform sustainable national scale-up. Well-designed projects can test multiple delivery strategies, implementation for challenging areas and populations, and integration with national systems. Introduction of vaccines or other health interventions, particularly those involving new target groups or delivery strategies, needs flexible funding approaches to address specific questions of scalability and sustainability, including learning lessons through phased national expansion. |
format | Online Article Text |
id | pubmed-5027708 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Taylor & Francis |
record_format | MEDLINE/PubMed |
spelling | pubmed-50277082016-11-01 The value of demonstration projects for new interventions: The case of human papillomavirus vaccine introduction in low- and middle-income countries Howard, N. Mounier-Jack, S. Gallagher, K. E. Kabakama, S. Griffiths, U. K. Feletto, M. LaMontagne, D. S. Burchett, H. E. D. Watson-Jones, D. Hum Vaccin Immunother Commentaries Demonstration projects or pilots of new public health interventions aim to build learning and capacity to inform country-wide implementation. Authors examined the value of HPV vaccination demonstration projects and initial national programmes in low-income and lower-middle-income countries, including potential drawbacks and how value for national scale-up might be increased. Data from a systematic review and key informant interviews, analyzed thematically, included 55 demonstration projects and 8 national programmes implemented between 2007-2015 (89 years' experience). Initial demonstration projects quickly provided consistent lessons. Value would increase if projects were designed to inform sustainable national scale-up. Well-designed projects can test multiple delivery strategies, implementation for challenging areas and populations, and integration with national systems. Introduction of vaccines or other health interventions, particularly those involving new target groups or delivery strategies, needs flexible funding approaches to address specific questions of scalability and sustainability, including learning lessons through phased national expansion. Taylor & Francis 2016-05-09 /pmc/articles/PMC5027708/ /pubmed/27159786 http://dx.doi.org/10.1080/21645515.2016.1178433 Text en © 2016 The Author(s). Published with license by Taylor & Francis. http://creativecommons.org/licenses/by-nc/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. The moral rights of the named author(s) have been asserted. |
spellingShingle | Commentaries Howard, N. Mounier-Jack, S. Gallagher, K. E. Kabakama, S. Griffiths, U. K. Feletto, M. LaMontagne, D. S. Burchett, H. E. D. Watson-Jones, D. The value of demonstration projects for new interventions: The case of human papillomavirus vaccine introduction in low- and middle-income countries |
title | The value of demonstration projects for new interventions: The case of human papillomavirus vaccine introduction in low- and middle-income countries |
title_full | The value of demonstration projects for new interventions: The case of human papillomavirus vaccine introduction in low- and middle-income countries |
title_fullStr | The value of demonstration projects for new interventions: The case of human papillomavirus vaccine introduction in low- and middle-income countries |
title_full_unstemmed | The value of demonstration projects for new interventions: The case of human papillomavirus vaccine introduction in low- and middle-income countries |
title_short | The value of demonstration projects for new interventions: The case of human papillomavirus vaccine introduction in low- and middle-income countries |
title_sort | value of demonstration projects for new interventions: the case of human papillomavirus vaccine introduction in low- and middle-income countries |
topic | Commentaries |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5027708/ https://www.ncbi.nlm.nih.gov/pubmed/27159786 http://dx.doi.org/10.1080/21645515.2016.1178433 |
work_keys_str_mv | AT howardn thevalueofdemonstrationprojectsfornewinterventionsthecaseofhumanpapillomavirusvaccineintroductioninlowandmiddleincomecountries AT mounierjacks thevalueofdemonstrationprojectsfornewinterventionsthecaseofhumanpapillomavirusvaccineintroductioninlowandmiddleincomecountries AT gallagherke thevalueofdemonstrationprojectsfornewinterventionsthecaseofhumanpapillomavirusvaccineintroductioninlowandmiddleincomecountries AT kabakamas thevalueofdemonstrationprojectsfornewinterventionsthecaseofhumanpapillomavirusvaccineintroductioninlowandmiddleincomecountries AT griffithsuk thevalueofdemonstrationprojectsfornewinterventionsthecaseofhumanpapillomavirusvaccineintroductioninlowandmiddleincomecountries AT felettom thevalueofdemonstrationprojectsfornewinterventionsthecaseofhumanpapillomavirusvaccineintroductioninlowandmiddleincomecountries AT lamontagneds thevalueofdemonstrationprojectsfornewinterventionsthecaseofhumanpapillomavirusvaccineintroductioninlowandmiddleincomecountries AT burchetthed thevalueofdemonstrationprojectsfornewinterventionsthecaseofhumanpapillomavirusvaccineintroductioninlowandmiddleincomecountries AT watsonjonesd thevalueofdemonstrationprojectsfornewinterventionsthecaseofhumanpapillomavirusvaccineintroductioninlowandmiddleincomecountries AT howardn valueofdemonstrationprojectsfornewinterventionsthecaseofhumanpapillomavirusvaccineintroductioninlowandmiddleincomecountries AT mounierjacks valueofdemonstrationprojectsfornewinterventionsthecaseofhumanpapillomavirusvaccineintroductioninlowandmiddleincomecountries AT gallagherke valueofdemonstrationprojectsfornewinterventionsthecaseofhumanpapillomavirusvaccineintroductioninlowandmiddleincomecountries AT kabakamas valueofdemonstrationprojectsfornewinterventionsthecaseofhumanpapillomavirusvaccineintroductioninlowandmiddleincomecountries AT griffithsuk valueofdemonstrationprojectsfornewinterventionsthecaseofhumanpapillomavirusvaccineintroductioninlowandmiddleincomecountries AT felettom valueofdemonstrationprojectsfornewinterventionsthecaseofhumanpapillomavirusvaccineintroductioninlowandmiddleincomecountries AT lamontagneds valueofdemonstrationprojectsfornewinterventionsthecaseofhumanpapillomavirusvaccineintroductioninlowandmiddleincomecountries AT burchetthed valueofdemonstrationprojectsfornewinterventionsthecaseofhumanpapillomavirusvaccineintroductioninlowandmiddleincomecountries AT watsonjonesd valueofdemonstrationprojectsfornewinterventionsthecaseofhumanpapillomavirusvaccineintroductioninlowandmiddleincomecountries |